The objective of this study was to assess the feasibility of single-inhalation xenon-enhanced computed tomography (XeCT) to provide clinically practical, high-resolution pulmonary ventilation imaging to clinics with access to only a single-energy computed tomography scanner, and to reduce the subject's overall exposure to xenon by utilizing a higher (70%) concentration for a much shorter time than has been employed in prior studies.
Introduction
Xenon (Xe) is a radio-opaque and inert gas; therefore, it may be a viable and safe gas-phase computed tomography (CT) contrast agent to quantify regional pulmonary ventilation in humans.
In order for such a contrast agent to be adopted widely, several clinical traits must be met: safety, convenience for the patient, and ease of implementation. Numerous studies have already explored the technical advantages of xenon-enhanced computed tomography (XeCT), such as its ability to provide reasonably safe high-resolution ventilation images. Dual-energy XeCT has been reported in patient and phantom studies (1) (2) (3) (4) (5) but most XeCT studies, to date, have used a multiple breath-hold technique in which patients inhale xenon for 1-2 minutes to reach equilibrium before image acquisition and xenon washout (1) (2) (3) (4) 6) .
There have also been research efforts to compare XeCT against currently available threedimensional ventilation imaging, that is, single-photon emission computed tomography (SPECT) (7) . Substantial agreement has recently been observed between XeCT and krypton-81m (Kr-81m) ventilation SPECT images in an intermodality blind analysis of lung ventilation defects (8) . With this result lending further credence to the use of gas-phase CT contrast agents for ventilation imaging, we aim to further expand upon its potential for future clinical implementation. By increasing the relative xenon concentration by a factor of two relative to prior studies, but reducing the xenon exposure to a single breath-hold duration (a factor of 5 or more reduction in exposure time compared to the studies noted earlier), a more rapid image acquisition may be possible with an overall reduction in patients' total exposure to xenon gas, a known anesthetic agent.
We therefore developed a single-inhalation, single-energy XeCT imaging method for clinical practicality, and we conducted a feasibility study in patients undergoing thoracic radiation therapy. A preliminary comparison was conducted between the XeCT ventilation images and a clinically available ventilation imaging technique with an inhaled radioactive aerosol (ventilation single-photon emission computed tomography-computed tomography [V-SPECT-CT]).
Materials and Methods

Patients
In an institutional review board-approved prospective clinical study of feasibility, XeCT was acquired for 15 patients and V-SPECT-CT scans were acquired for 11 of the 15 patients. Eligible patients were those scheduled to undergo thoracic radiation therapy, and XeCT was acquired in conjunction with radiation therapy treatment planning scans. To administer xenon for this indication, we obtained an investigator-sponsored investigational new drug approval from the Food and Drug Administration for pulmonary CT imaging with xenon (investigational new drug no. 115882). Written informed consent was obtained from all patients before the administration of xenon. We characterized patients with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria, which grades severity of disease based on pulmonary function tests from a scale of I to IV (9) . Children and pregnant women were excluded from the present study.
Assessment of Adverse Events
Patient clinical status was assessed by a board-certified physician in radiation oncology (BWL) during and after the XeCT imaging session to monitor for adverse events. Side effects were scored by the common terminology criteria for adverse events (CTCAE v. 4.03).1
Relation of Hounsfield Unit and Xenon Concentration at Different X-ray Energies
A sealed rubber bag filled with eight different xenon and room air mixtures (0%, 5.83%, 11.7%, 23.3%, 35%, 46.7%, 58.3%, and 70% xenon) was scanned with a Biograph mCT PET/CT scanner (Siemens Medical Solutions, Hoffman Estates, IL) with five different x-ray energy beams (70, 80, 100, 120, and 140 kV) at room temperature. Images were acquired using a tube current of 200 mAs, with 1.2-mm slice thickness, and medium smooth reconstruction kernel (B30s).
Video Biofeedback System
A custom video biofeedback system was used to facilitate achieving reproducible deep inhalation breath-hold levels to minimize errors in image alignment (10) . Before the administration of the xenon gas and scans, patients were given instructions by the study investigators, familiarized with the ventilation apparatus, and allowed to practice breath holds with oxygen without administering xenon gas.
XeCT Imaging
Breath-hold CT scans were acquired on a Biograph mCT PET/CT scanner (Siemens Medical Solutions), using the following settings: 80 kVp (100 kVp for two patients), 125-325 mAs (195 mAs for eight patients), 2-mm slice thickness, 0.97 × 0.97 mm 2 pixel size, and a smooth reconstruction kernel (B20f).
Xe-O2 was delivered to the patient using a gas delivery system as shown in Figure 1 . The mouthpiece assembly was designed to have a minimum amount of dead space, thereby allowing a more efficient delivery of contrast agent to the patient's lungs. The inhalation gas was switched between Xe-O2 and O2 by opening and closing balloon valves that were remotely controlled at the on-site workstation. An infrared reflector (RPM; Varian Medical Systems, Palo Alto, CA) was placed on each patient's abdomen to provide a breathing trace to cue the investigators to toggle between the ventilation gases. XeCT imaging protocols consisted of (1) acquisition of a breath-hold CT scan after a single inhalation of 100% oxygen and (2) acquisition of a breathhold CT scan after a single inhalation of a 70% xenon-30% oxygen mix. Patients were coached to exhale completely before each inhalation breath hold.
Deformable Image Registration Method
To minimize interscan variability when performing image subtraction between pre-and postxenon inhalation scans, we developed an intensity-based free-form deformable image registration (DIR) workflow using the Elastix toolkit (11, 12) . We coregistered the breath-hold images before and after inspiration of xenon (13, 14) , and we employed lung masks and a multiscale vesselness filter (15) to further guide the intensity-based deformation process. Lung masks were generated using a Hounsfield unit window between −1024 and −300 HU. The lung vasculature was included in the DIR masks via morphologic closing of the Hounsfield unitdefined contours, but was subsequently excluded from statistical analyses where regional ventilation of the parenchyma was being assessed. Visual inspection was performed on the deformation vector field to verify the absence of nonphysical transformations (such as folding or tearing). Figure 2a and b illustrates how the two sequential CT images are combined to form difference images without ( Fig 2c) and with (Fig 2d) DIR.
SPECT-CT Imaging
V-SPECT-CT was performed by the standard clinical protocol at our institution. Forty millicurie of 99m Tc-DTPA was aerosolized using a standard technique, and approximately 1 mCi was inhaled by the patient in a supine position with slow, moderately deep breathing. SPECT-CT images were then acquired using a GE Infinia Hawkeye 8-slice SPECT-CT scanner (Milkwaukee, WI). SPECT projections were acquired in a 64 × 64 matrix with an 8.84 × 8.84 mm 2 pixel size, 8.84-mm slice spacing, 60 projections over 360°, and 30 seconds per projection during tidal breathing, for a total of 300K counts. The SPECT images were reconstructed with attenuation correction using the CT images.
Analysis of XeCT Images and Correlation with V-SPECT-CT
After image acquisition, DIR spatially aligned the two breath-hold images with each other. Then Xe concentration was calculated by subtraction between Xe-O2 and O2 images, which yields a high-resolution map of regional distribution of Xe. Each of the XeCT quantitative images of regional lung ventilation and their physiological accuracy was compared to aerosol-based V-SPECT-CT, a technique for the generation of ventilation imagery that is widely available but has known limitations (16) . Figure 3 , each lung was divided into 12 sectors and correlated with the mean Hounsfield unit enhancement at each sector with the median V-SPECT-CT count of the corresponding sector of the lung. The Spearman rank correlation coefficient, a nonparametric measure of statistical dependence, and the Pearson linear correlation coefficient, a measure of the strength of linear dependence, were determined to quantify the correlation between each pair of scans.
As shown in
Statistical Analysis
The data, consisting of XeCT and V-SPECT-CT, were analyzed in a hierarchical model with repeated measurements within patients and with the assumption that the variance-covariance structure followed a compound symmetry structure. The Spearman rank correlation coefficient and the Pearson linear correlation coefficient were determined to quantify the correlation between XeCT and V-SPECT-CT images. All analyses were performed using the Scipy statistics package for Python (version 3.5).
Results
Patient Characteristics
Between December 2013 and July 2014, 15 patients (11 men and 4 women) met the eligibility criteria and were enrolled in the study. Patient characteristics are summarized in Table 1 . Their age ranged from 55 to 79 (66 ± 7) years. One patient had no pulmonary function test and nine patients had COPD, across all GOLD stages with a forced expiratory volume of 39-107 (65 ± 20). The cohort average lung volume was 5.3 ± 1.6 L. Eleven of the 15 patients consented to acquisition of both XeCT and V-SPECT-CT scans (designated as patients 1-11). Four patients had XeCT only (designated as patients X1-X4).
Technical Feasibility and Side Effects
We successfully obtained XeCT images for 10 of the 15 patients. Patients 2, 4, 10, 11, and X4 had technical failure of XeCT because of inaccurate synchronization of inhalation with Xe gas delivery: in one case, the patient inhaled room air around the mouthpiece of the gas delivery system at the time of xenon delivery. Subsequently, we switched to the use of snorkel mouthpieces to prevent open-mouth breathing. The remaining four patients with technical failures had incorrect determination of completeness of exhalation before xenon inhalation with the existing biofeedback system, leading to an incorrect timing of xenon inhalation. Because of the higher experimental concentration of xenon, the patients were not asked to repeat the inhalation-scanning procedure, and these cases were subsequently logged as technical failures. Successful inhalation of the xenon mixture was confirmed by measurement of the xenon concentration in the central airways (shown with the lung masks in Fig A1 and tabulated in Table  1 ). Five of 15 patients experienced transient grade 1 dizziness lasting less than 1 minute immediately after the breath hold of the Xe gas mixture that resolved after switching back to oxygen breathing. There were no other side effects.
Relation of Hounsfield Unit and Xenon Concentration at Different X-ray Energies
The mean Hounsfield units of voxels within the inflatable rubber bag were measured in each image set at each xenon concentration and were plotted against the xenon concentration for different x-ray energies. The mean Hounsfield units of the xenon in the bag were linearly related to xenon concentration as apparent in Figure 4 . Slopes and intercepts of linear regression equations and regression coefficients (R 2 ) were, respectively, 2.46, −1000.4, and 0.99 for 70-kV images; 2.16, −1001, and 0.99 for 80-kV images; 1.70, −1000, and 0.99 for 100-kV images; 1.43, −999.89, and 0.99 for 120-kV images; and 1.27, −1000.4, and 0.99 for 140-kV images. The maximum enhancement was 175 HU for a xenon concentration of 70% at 70 kV. Table 1 shows the Spearman correlation coefficients and the Pearson correlation coefficients between the mean xenon concentration and the V-SPECT-CT counts at corresponding sectors for each patient. The single-breath xenon inspiration was deemed to be successful when the mean Hounsfield unit difference within the trachea and the primary bronchial tree was greater than 80 HU. Patients who achieved a successful inspiration displayed a difference of 116 ± 16 HU, whereas patients with technical failures exhibited a difference of 16 ± 19 HU. Figure 5 shows the corresponding coronal XeCT and V-SPECT-CT images, along with the calculated correlation between XeCT and V-SPECT-CT at the corresponding sectors for two patients (patients 1 and 8) with images displaying a high degree of heterogeneity of ventilation throughout the lungs. There was a clear visual concordance (and strong Spearman correlation coefficient) between the two image modalities for these patients. Figure A1 in the Appendix shows the corresponding coronal XeCT and V-SPECT-CT image pairs for all patients in our study who underwent both types of scan (designated as patients 1-11), along with a plot of the ventilation signals from corresponding sectors of the two imaging studies. Notably, patients 3, 5, 6, 7, and 9 demonstrated much more homogeneous XeCT ventilation maps than patients 1 and 8. Figure A2 in the Appendix shows the corresponding coronal XeCT for patients who had XeCT only (designated patients X1-X4).
Ventilation Maps
Discussion
We have developed an imaging method to determine the spatial distribution of xenon gas (during a single 70% xenon inhalation maneuver) as a measure of regional ventilation, and conducted here a first in human feasibility study of the method in a single-energy CT scanner. Singleinhalation, single-energy XeCT was technically successful in 10 of 15 patients, and the five technical failures were attributable to incorrect synchronization between the inhalation and the delivery of the Xe gas mixture. These failures can be corrected in the future by improvements to the biofeedback system, such as increased patient training, as well as the implementation of a spirometry-based breathing surrogate signal that measures the volume of air moved as a surrogate for the degree of lung expansion. This approach would provide a more ideal feedback signal than our currently implemented infrared reflector positioned on the patient's abdomen.
Finally, we compared XeCT ventilation to V-SPECT-CT, which is a clinically available threedimensional ventilation imaging modality. The voxel values of the xenon-enhanced images were related to the degree of ventilation magnitude. Of seven evaluable patients, two (patients 1 and 8) had a high correlation between regional Xe concentration and SPECT emission counts. For patient 8, paralysis of the left hemidiaphragm was associated with decreased ventilation throughout the entire left lung. In contrast, five patients (patients 3, 5, 6, 7, and 9) demonstrated low correlation between XeCT and V-SPECT-CT. These patients had either normal (patients 3 and 5) or diminished (patients 6, 7, and 9) lung function as assessed by spirometry, but with homogeneous distribution. Because ventilation between sectors was relatively homogeneous, any observed variability is dominated by random noise; therefore, when these XeCT images are compared on a sector-wise basis with alternate image modalities, strong Spearman correlations are unlikely to be observed. The different parameters for contrast administration (deepinspiration breath hold of a gaseous agent vs free breathing of a nebulized aerosol) suggest that perfect correlation may not actually be achievable when comparing the two imaging modalities. Furthermore, the relatively narrow spread of xenon ventilation signal (the y-axis ranges observed in the Fig A1 subplots) is small compared to the dynamic range of the SPECT counts (x-axis ranges). This finding would make the intermodality correlation more susceptible to the bright central airway artifacts that are seen in the corresponding SPECT images.
Our proposed single breath-hold single-energy CT method for quantifying regional lung ventilation demonstrates several benefits. With only a single xenon inhalation, we can use a higher concentration of xenon (70% xenon and 30% oxygen) than possible with previous XeCT techniques and observe no side effects other than transient (Grade 1) dizziness while simultaneously providing greater contrast and dynamic range compared to prior studies 5, 17 and better sensitivity at low ventilation regions. We chose 80 kVp to trade between higher attenuation by xenon (Fig 4) and better quality anatomic imaging of the lung. The use of a single-energy CT scanner also makes this method widely accessible. Furthermore, with the use of video biofeedback for improved breath-hold reproducibility, only a minimal application of lung deformable registration is needed, and this is easily achieved by most commercial DIR software packages. For example, the image processing workflow and analysis from the present study was fully replicated (except for the vesselness-based registration mask) using a commercially available MIM Maestro package (MIM Software Inc., Cleveland, OH) that has been optimized for clinical use. Similar results were obtained, with patients 1 and 8 again demonstrating the strongest sector-wise Spearman correlations with V-SPECT-CT (ρ ≥ 0.75, P < .001), although these XeCT ventilation images (generated with clinical software) have more pronounced blood vessel misregistration artifacts throughout the lungs. The coarse scaling of the sector-wise analysis (12 segments per lung) is apparently robust to minor registration artifacts that impact only a small fraction of each lung sector.
Despite many recent advances in medical imaging technology, there is no clinical imaging method that permits quantitative high-resolution regional assessment of ventilation within the lung. Hence, a broadly available high-resolution quantitative functional imaging method is needed. For patients suffering from lung cancer treated with radiation therapy, regional ventilation may be used for tracking the progression of radiation-induced toxicity to nearby normal tissues during treatment and can be used to evaluate treatment planning methods to reduce radiation toxicity to the most functional portions of the lung (18-23). Regional lung function information may also be used for lung disease therapy planning, such as lung volume reduction surgery, to improve lung biomechanics and the quality of life for certain patients with emphysema or to optimize ventilator management for patients with acute respiratory distress syndrome (24) . Regional lung function information may also be useful for the diagnosis and monitoring of pulmonary diseases such as COPD (25) .
Nuclear medicine imaging (most commonly planar imaging) is a commonly utilized technique for ventilation assessment. By comparison, advantages of the XeCT method demonstrated in the present study include higher resolution, volumetric imaging, improved quantitation, shorter study time, and lack of aerosol deposition artifacts in the airways. Notably, newer radiolabeled gases or aerosols for use with nuclear medicine ventilation imaging such as Ga-68 aerosol (Galligas) (26, 27) , an ultrafine dispersion of 99m Tc-labeled carbon (Technegas) (28, 29) , and radioactive Xe-133 gas (30) can reduce airway deposition artifacts, but are not currently approved for clinical use in the United States.
Different gases have been used as gas-phase contrast agents for pulmonary imaging, including krypton (31, 32) and xenon (1) (2) (3) (4) (5) 29) . However, these methods have typically used either dualenergy CT scanners or hyperpolarized MRI, which require specialized equipment that is not widely available, or used longer wash-in times for contrast inhalation. The recent work by Ohno et al. with a gas-phase (krypton) SPECT contrast agent is an encouraging affirmation of the equivalence between XeCT and SPECT, and their mode of contrast agent delivery is also not impacted by aerosol deposition artifacts (8) . A significant proportion of the patient population undergoing thoracic radiotherapy presents with obstructive disease that can trap aerosols in the central airways, so it is likely that gaseous contrast agents will find better application within the radiation oncology field.
The size of our patient cohort is the primary limitation of the present study. Larger studies will be required for comprehensive validation. Furthermore, the dose of a XeCT scan at 80 kVp with sufficient exposure to match the noise characteristics of a standard diagnostic chest CT is approximately 4.2 mSv, which is significantly higher than that of V-SPECT-CT at 0.7 mSv. Nevertheless, the dose is still lower than a standard diagnostic chest CT acquired at 120 kVp (approximately 9.3 mSv).
In conclusion, single-inhalation, single-energy XeCT has the potential to quantify regional lung ventilation volumetrically and with high resolution using widely accessible radiological equipment. Higher concentrations of inhaled xenon (70%) can be safely administered and can provide enough contrast such that only a single inspiration may be necessary to characterize regional lung defects. Clinically available medical image analysis software can be utilized to process XeCT ventilation images. Figure A2 . Xenon-enhanced computed tomography image for four patients who did not receive the concurrent (but optional) ventilation single-photon emission computed tomographycomputed tomography image during the study. Another advantage for xenon-enhanced computed tomography-based ventilation is that single-photon emission computed tomography hardware is not often accessible to patients undergoing radiation therapy.
